For this purpose, a clinical study was performed on patients with advanced rectal cancer (LARC) with a follow-up of more than 5 years, for which the possible correlation between the expression of MDL1/MDL1AS and LARC patient survival is investigated. The gene discussed is CLEC5A; the disease is rectal cancer.